These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18465362)

  • 21. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.
    Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J
    BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes mellitus and colorectal neoplasia risk in Hispanics: a case-control study.
    Díaz-Algorri Y; Lozada ME; López SM; Bertrán-Rodríguez CE; González-Hernández CM; González D; Pérez-Cardona CM; Hernández J; Pedrosa C; Toro DH; González-Pons M; Cruz-Correa M
    J Diabetes Complications; 2015; 29(4):502-7. PubMed ID: 25784088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
    Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
    Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus.
    Wang JL; Chang CH; Lin JW; Wu LC; Chuang LM; Lai MS
    Int J Cancer; 2014 Aug; 135(4):956-67. PubMed ID: 24470385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
    Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Colorectal cancer and diabetes].
    Svacina S
    Vnitr Lek; 2011 Apr; 57(4):378-80. PubMed ID: 21612063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus.
    Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1170-5. PubMed ID: 22563104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes and cancer: Could vitamin D provide the link?
    Ahmad S; Chowdhury TA; Boucher BJ
    J Diabetes Complications; 2013; 27(2):184-90. PubMed ID: 23164631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperinsulinemia in patients with colorectal cancer.
    Suehiro T; Matsumata T; Shikada Y; Sugimachi K
    Hepatogastroenterology; 2005; 52(61):76-8. PubMed ID: 15782998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Colorectal carcinoma and diabetes mellitus].
    Procházka V; Chlup R
    Vnitr Lek; 2008 Oct; 54(10):979-84. PubMed ID: 19009765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.
    Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH
    Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
    Gallagher EJ; LeRoith D
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin: A Salutary Candidate for Colorectal Cancer Treatment in Patients with Diabetes.
    Samuel VP; Dahiya R; Singh Y; Gupta G; Sah SK; Gubbiyappa SK; Chellappan DK; Dua K
    J Environ Pathol Toxicol Oncol; 2019; 38(2):133-141. PubMed ID: 31679276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.
    Peeters PJ; Bazelier MT; Leufkens HG; de Vries F; De Bruin ML
    Diabetes Care; 2015 Mar; 38(3):495-502. PubMed ID: 25552419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis.
    Wang L; Cai S; Teng Z; Zhao X; Chen X; Bai X
    Diagn Pathol; 2013 Oct; 8():180. PubMed ID: 24175949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes mellitus and colorectal cancer risk.
    La Vecchia C; Negri E; Decarli A; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1007-10. PubMed ID: 9419395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
    Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
    Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes.
    Overbeek JA; Kuiper JG; van der Heijden AAWA; Labots M; Haug U; Herings RMC; Nijpels G
    Int J Colorectal Dis; 2019 Feb; 34(2):269-276. PubMed ID: 30421309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.